Detalhe da pesquisa
1.
SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.
Cell
; 184(9): 2362-2371.e9, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33735608
2.
Infectivity and antigenicity of pseudoviruses with high-frequency mutations of SARS-CoV-2 identified in Portugal.
Arch Virol
; 167(2): 459-470, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35083576
3.
A second functional furin site in the SARS-CoV-2 spike protein.
Emerg Microbes Infect
; 11(1): 182-194, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34856891
4.
The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain.
Signal Transduct Target Ther
; 7(1): 18, 2022 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35046385
5.
Analysis of SARS-CoV-2 variants B.1.617: host tropism, proteolytic activation, cell-cell fusion, and neutralization sensitivity.
Emerg Microbes Infect
; 11(1): 1024-1036, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35293847
6.
The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom.
Front Immunol
; 12: 687869, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34220844
7.
Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization.
Commun Biol
; 4(1): 1196, 2021 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34645933
8.
The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients.
Front Immunol
; 12: 632814, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33763078
9.
Antibody-dependent cellular cytotoxicity response to SARS-CoV-2 in COVID-19 patients.
Signal Transduct Target Ther
; 6(1): 346, 2021 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34561414
10.
Cellular tropism and antigenicity of mink-derived SARS-CoV-2 variants.
Signal Transduct Target Ther
; 6(1): 196, 2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34001855